Search

everythinglearnresearchcommunity

for

Search:↓

HairMax LaserComb® effectively promotes hair growth and stops hair loss in males with androgenetic alopecia, with no serious side effects.

Laser device increases hair density, safe for treating hair loss in men and women.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

BLIMP1 is essential for skin maintenance but not for defining sebaceous gland progenitors.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Rosemary leaf extract may be an effective natural treatment for hair growth and male pattern baldness.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Using finasteride with TIP extends time off period for prostate cancer patients.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.